219 related articles for article (PubMed ID: 34107703)
1. A noninvasive diagnostic model for significant liver fibrosis in patients with chronic hepatitis B based on CHI3L1 and routine clinical indicators.
Huang Q; Wu J; Huang C; Wang X; Xu Z
Ann Palliat Med; 2021 May; 10(5):5509-5519. PubMed ID: 34107703
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.
Ma J; Jiang Y; Gong G
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):428-34. PubMed ID: 23358121
[TBL] [Abstract][Full Text] [Related]
3. Plateletcrit as a potential index for predicting liver fibrosis in chronic hepatitis B.
Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
J Viral Hepat; 2020 Jun; 27(6):602-609. PubMed ID: 31981279
[TBL] [Abstract][Full Text] [Related]
4. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of serum chitinase-3-like protein 1 in chronic liver disease of significant fibrosis and cirrhosis].
Li H; Yan T; Zhu Z; Bao ZW; Xu TM; Xie J; Zheng SQ; Cui MM; Liu LG
Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):337-341. PubMed ID: 29996200
[No Abstract] [Full Text] [Related]
6. A novel noninvasive index for the prediction of moderate to severe fibrosis in chronic hepatitis B patients.
Li J; Mao RC; Li XL; Zheng JW; Qi X; Yuan Q; Zhang J; Zhang JM; Xia NS
Dig Liver Dis; 2018 May; 50(5):482-489. PubMed ID: 29396134
[TBL] [Abstract][Full Text] [Related]
7. [Establishment and preliminary application of serum Golgi protein 73 based noninvasive diagnostic model for compensated stage hepatitis B cirrhosis].
Zhai XW; Liu SH; Yao MJ; Qian XJ; Wen XJ; Xu Q; Zhao JM; Lu FM
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):47-52. PubMed ID: 32023699
[No Abstract] [Full Text] [Related]
8. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
Li Q; Lu C; Li W; Huang Y; Chen L
Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
[TBL] [Abstract][Full Text] [Related]
9. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
[TBL] [Abstract][Full Text] [Related]
10. Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.
Zeng DW; Liu YR; Zhang JM; Zhu YY; Lin S; You J; Li YB; Chen J; Zheng Q; Jiang JJ; Dong J
PLoS One; 2013; 8(10):e77942. PubMed ID: 24282481
[TBL] [Abstract][Full Text] [Related]
11. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of serum chitinase 3-like 1 in hepatitis B-related chronic liver diseases.
Jiang Z; Wang S; Jin J; Ying S; Chen Z; Zhu D; Xiao B; Hu Y; Qian Y; Cai T; Fu L
J Clin Lab Anal; 2020 May; 34(5):e23200. PubMed ID: 31916309
[TBL] [Abstract][Full Text] [Related]
13. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
Kim BK; Kim DY; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Han KH
Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
[TBL] [Abstract][Full Text] [Related]
14. A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
Chen Y; Wang Y; Chen Y; Yu Z; Chi X; Hu KQ; Li Q; Tan L; Xiang D; Shang Q; Lei C; Chen L; Hu X; Wang J; Liu H; Lu W; Chi W; Dong Z; Wang X; Li Z; Xiao H; Chen D; Bai W; Zhang C; Xiao G; Qi X; Chen J; Zhou L; Sun H; Deng M; Qi X; Zhang Z; Qi X; Yang Y
Clin Transl Gastroenterol; 2019 May; 10(5):1-12. PubMed ID: 31033506
[TBL] [Abstract][Full Text] [Related]
15. [Study on heme oxygenase-1 and HAP model for the diagnosis of chronic hepatitis B-related liver fibrosis].
Xue NN; Yuan XW; Zhao W; Tang YH; Zhang XX; Wang YQ; Zhao DD; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2021 Aug; 29(8):743-747. PubMed ID: 34517454
[No Abstract] [Full Text] [Related]
16. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
[TBL] [Abstract][Full Text] [Related]
18. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.
Lin CL; Liu CH; Wang CC; Liang CC; Su TH; Liu CJ; Kao JH
J Clin Gastroenterol; 2015 Sep; 49(8):705-13. PubMed ID: 25319739
[TBL] [Abstract][Full Text] [Related]
19. Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China.
Jin X; Fu B; Wu ZJ; Zheng XQ; Hu JH; Jin LF; Tang LL
Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):384-389. PubMed ID: 32540209
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.
Liu YR; Lin BB; Zeng DW; Zhu YY; Chen J; Zheng Q; Dong J; Jiang JJ
BMC Gastroenterol; 2014 Aug; 14():145. PubMed ID: 25128299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]